PT66781B - Procede pour la preparation des derives de la phenoxy-hydroxypropylamine - Google Patents
Procede pour la preparation des derives de la phenoxy-hydroxypropylamineInfo
- Publication number
- PT66781B PT66781B PT66781A PT6678177A PT66781B PT 66781 B PT66781 B PT 66781B PT 66781 A PT66781 A PT 66781A PT 6678177 A PT6678177 A PT 6678177A PT 66781 B PT66781 B PT 66781B
- Authority
- PT
- Portugal
- Prior art keywords
- phenoxy
- preparation
- hydroxypropylamine
- derivatives
- hydroxypropylamine derivatives
- Prior art date
Links
- LBSOXWCAEGGPDY-UHFFFAOYSA-N 3-(phenoxyamino)propan-1-ol Chemical class OCCCNOC1=CC=CC=C1 LBSOXWCAEGGPDY-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D309/06—Radicals substituted by oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3064776 | 1976-07-22 | ||
| GB5357676 | 1976-12-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT66781A PT66781A (fr) | 1977-08-01 |
| PT66781B true PT66781B (fr) | 1978-12-18 |
Family
ID=26260544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT66781A PT66781B (fr) | 1976-07-22 | 1977-07-08 | Procede pour la preparation des derives de la phenoxy-hydroxypropylamine |
Country Status (11)
| Country | Link |
|---|---|
| JP (1) | JPS5312851A (fr) |
| AU (1) | AU2714177A (fr) |
| DE (1) | DE2733305A1 (fr) |
| DK (1) | DK329577A (fr) |
| ES (1) | ES460866A1 (fr) |
| FR (1) | FR2359135A1 (fr) |
| GR (1) | GR61995B (fr) |
| NL (1) | NL7707949A (fr) |
| NO (1) | NO772604L (fr) |
| PT (1) | PT66781B (fr) |
| SE (1) | SE7708368L (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58160154U (ja) * | 1983-03-01 | 1983-10-25 | セイコーエプソン株式会社 | 印字装置 |
| GB0319069D0 (en) * | 2003-08-14 | 2003-09-17 | Glaxo Group Ltd | Therapeutically useful compounds |
| EA011010B1 (ru) | 2004-02-27 | 2008-12-30 | Эмджен, Инк. | Соединения, модулирующие рецептор gpr40, фармацевтическая композиция, способ лечения заболеваний, чувствительных к модулированию рецептора gpr40 (варианты), способ модулирования функции gpr40 (варианты) и способ модулирования циркулирующей концентрации инсулина |
| US7465804B2 (en) | 2005-05-20 | 2008-12-16 | Amgen Inc. | Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders |
| WO2007033002A1 (fr) | 2005-09-14 | 2007-03-22 | Amgen Inc. | Acides propanoïques 3-substitués par un groupement 4-hydroxyphényle à conformation contrainte pouvant être employés dans le traitement de troubles métaboliques |
| WO2008030618A1 (fr) | 2006-09-07 | 2008-03-13 | Amgen Inc. | Composés benzo-fusionnés destinés à être utilisés dans le traitement de troubles métaboliques |
| CA2662305C (fr) | 2006-09-07 | 2012-04-17 | Amgen Inc. | Modulateurs heterocycliques du recepteur couple a la proteine g (gpr40) |
| US7572934B2 (en) | 2007-04-16 | 2009-08-11 | Amgen Inc. | Substituted biphenyl GPR40 modulators |
| BRPI0818253A2 (pt) | 2007-10-10 | 2015-04-07 | Amgen Inc | Moduladores de gpr40 bifenil substituídos |
| WO2009111056A1 (fr) | 2008-03-06 | 2009-09-11 | Amgen Inc. | Dérivés d'acide carboxylique conformationnellement dépendants, utiles dans le traitement de troubles du métabolisme |
| JP5551707B2 (ja) | 2008-10-15 | 2014-07-16 | アムジエン・インコーポレーテツド | スピロ環ｇｐｒ４０調節因子 |
| WO2025140637A1 (fr) * | 2023-12-28 | 2025-07-03 | 赛岚(杭州)生物医药科技有限公司 | Composé inhibiteur de tdg et son utilisation |
-
1977
- 1977-07-01 FR FR7720380A patent/FR2359135A1/fr not_active Withdrawn
- 1977-07-08 PT PT66781A patent/PT66781B/fr unknown
- 1977-07-09 GR GR53932A patent/GR61995B/el unknown
- 1977-07-15 NL NL7707949A patent/NL7707949A/xx not_active Application Discontinuation
- 1977-07-19 ES ES77460866A patent/ES460866A1/es not_active Expired
- 1977-07-19 AU AU27141/77A patent/AU2714177A/en active Pending
- 1977-07-20 DK DK329577A patent/DK329577A/da unknown
- 1977-07-20 SE SE7708368A patent/SE7708368L/xx unknown
- 1977-07-21 DE DE19772733305 patent/DE2733305A1/de active Pending
- 1977-07-21 NO NO77772604A patent/NO772604L/no unknown
- 1977-07-22 JP JP8826877A patent/JPS5312851A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES460866A1 (es) | 1978-08-16 |
| SE7708368L (sv) | 1978-01-23 |
| JPS5312851A (en) | 1978-02-04 |
| DE2733305A1 (de) | 1978-01-26 |
| AU2714177A (en) | 1979-01-25 |
| FR2359135A1 (fr) | 1978-02-17 |
| GR61995B (en) | 1979-02-14 |
| DK329577A (da) | 1978-01-23 |
| NL7707949A (nl) | 1978-01-24 |
| PT66781A (fr) | 1977-08-01 |
| NO772604L (no) | 1978-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RO70769A (fr) | Procede pour la preparation des derives de 2-phenyle-3-acylbenzothiophene | |
| RO82375A (fr) | Procede pour la preparation des derives de 9-aminodibenzopyrane | |
| RO70768A (fr) | Procede pour la preparation des derives de 2-aryle-5-phenylbenzothiophene | |
| RO73517A (fr) | Procede pour la preparation des derives aminoglycosidiques | |
| PT64912A (fr) | Procede pour la preparation de derives de salicilanilide | |
| RO70854A (fr) | Procede pour la preparation des metha-aryloxybenzaldehydes | |
| RO80925A (fr) | Procede pour la preparation des derives de nitrothiofene | |
| RO79164A (fr) | Procede pour la preparation des derives de 1-allyle-triazole | |
| PT66781A (fr) | Procede pour la preparation des derives de la phenoxy-hydroxypropylamine | |
| RO78658A (fr) | Procede pour la preparation des derives des antraquinonsulfonamides | |
| RO70462A (fr) | Procede pour la preparation des 3-halomethylcephem | |
| RO76587A (fr) | Procede pour la preparation des derives de 1,3,4 triadiazole | |
| RO78091A (fr) | Procede pour la preparation des derives de 1-azoletene | |
| RO71572A (fr) | Procede pour la preparation des oxycarbamates n-sulphenyles | |
| RO71066A (fr) | Procede pour la preparation des 2-chlorsulfinylazetidin-4-ones | |
| RO79264A (fr) | Procede pour la preparation des derives de oleandomicine | |
| RO72900A (fr) | Procede pour la preparation des cis-4a-phenyloctahydro-1h-2-pyrindines | |
| FR2351967A1 (fr) | Procede de preparation de derives de 3-benzazepines | |
| RO80266A (fr) | Procede pour la preparation des derives de 1-amino-2-alcoolpropylique | |
| RO78802A (fr) | Procede pour la preparation des derives de n-trifluoraracetyle-n-phosphonomethylglycine | |
| PT71444A (fr) | Procede pour la preparation de derives de benzimydazole | |
| RO83713A (fr) | Procede pour la preparation des haloacylamides | |
| BE879821A (fr) | Procede selectif pour la preparation de derives de 7-hydroxy-coumarine | |
| RO76125A (fr) | Procede pour la preparation des derives de furanne | |
| FR2366259B1 (fr) | Procede de preparation de derives de nitroalcanols |